Key result
Male gender is linked to lower 30-day TAVI mortality but similar long-term survival versus women.
Why the study?
Are there gender-related differences in short- and long-term outcomes among patients with inoperable or high-risk symptomatic aortic stenosis undergoing TAVI?
Cohort (n=819)
Yes
Are there gender-related differences in short- and long-term outcomes among patients with inoperable or high-risk symptomatic aortic stenosis undergoing TAVI?
Women undergoing TAVI have higher 30-day mortality driven by bleeding and vascular complications, but long-term mortality is similar to men.
Answers are grounded in this paper and cite their sources.
Short-term mortality difference by sex after TAVI needs validation; leaves open whether gender influences outcomes independently of confounders.
OBJECTIVES: This study aimed to compare gender-related differences in outcomes of patients undergoing TAVI over a long-term follow-up period. BACKGROUND: Transcatheter aortic valve implantation (TAVI) has been considered the standard therapy for patients with inoperable or high-risk symptomatic aortic stenosis. The influence of gender-related differences in outcomes of patients undergoing TAVI is currently on debate. METHODS: From January 2008 to January 2015, 819 patients (49% men) underwent TAVI and were included in a multicenter Brazilian registry. Patients were followed-up and clinical outcomes were evaluated according to the updated Valve Academic Research Consortium-2 criteria. RESULTS: Mean follow-up was 497 ± 478 days. Compared with women, men had a lower rate of major or life-threatening bleeding (12.0% vs. 20.6%; HR = 0.57 [95CI% 0.40-0.81]; P = 0.001), and major vascular complications (6% vs. 11.7%; HR = 0.50 [95CI% 0.31-0.82]; P = 0.004). At 30 days, all-cause mortality was lower in men than in women (6.5% vs. 11.5%; P = 0.013), however, cumulative all-cause mortality was similar between groups (25.9% vs. 29.7%, men and women, respectively, HR = 0.92 [95CI% 0.71-1.19]; P = 0.52) over the entire follow-up period. By adjusted Cox regression model, renal function, diabetes, peripheral artery disease, and chronic obstructive pulmonary disease (COPD) remained independently predictors of all-cause mortality. CONCLUSIONS: In this large-scale study evaluating patients undergoing TAVI, 30-day mortality was higher among women than men driven by significant higher rates of major or life-threatening bleeding and major vascular complications. However, all-cause mortality on long-term follow-up was similar between groups.
No takes yet. Share an insight, caveat, or question.
Katz et al. (2016) conducted a cohort in Inoperable or high-risk symptomatic aortic stenosis (n=819). Male gender vs. Female gender was evaluated on Cumulative all-cause mortality (HR 0.92, 95% CI 0.71-1.19, p=0.52). Male gender was associated with lower 30-day mortality after TAVI compared to women, but long-term cumulative all-cause mortality was similar.
Synapse has enriched 10 related papers. Consider them for comparative context: